VOR BIOPHARMA INC. - COMMON STOCK

Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs

17 6 2021 08:00:01 提供 Nasdaq GlobeNewswire

Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

11 6 2021 08:00:00 提供 Nasdaq GlobeNewswire

Vor to Develop Multi-Targeted CAR-Ts with Abound Bio

10 6 2021 08:00:01 提供 Nasdaq GlobeNewswire

Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences

25 5 2021 16:10:00 提供 Nasdaq GlobeNewswire

Vor Reports First Quarter 2021 Financial Results and Provides Company Update

06 5 2021 16:08:56 提供 Nasdaq GlobeNewswire

Vor To Present on VOR33 Manufacturing Scale-Up and Off-Target Editing at ASGCT

28 4 2021 08:00:01 提供 Nasdaq GlobeNewswire

Vor Reports Fiscal Year 2020 Financial Results

25 3 2021 16:35:00 提供 Nasdaq GlobeNewswire

Vor Biopharma to Present at the Barclays Global Healthcare Conference

05 3 2021 15:00:00 提供 Nasdaq GlobeNewswire

Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference

01 3 2021 15:45:00 提供 Nasdaq GlobeNewswire

Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares

09 2 2021 16:05:00 提供 Nasdaq GlobeNewswire

Vor Biopharma Announces Pricing of Initial Public Offering

05 2 2021 06:33:42 提供 Nasdaq GlobeNewswire